Treatment of tuberculosis.

Critical reflections on evidence, ethics and effectiveness in the management of tuberculosis: public health and global perspectives. BMC Med Ethics (2004) 1.14

Prescribing and taking medicines. BMJ (2003) 1.07

Tuberculous pericarditis with and without HIV. Heart Fail Rev (2013) 0.93

Single-Stranded DNA Aptamers against Pathogens and Toxins: Identification and Biosensing Applications. Biomed Res Int (2015) 0.81

A comparative analysis of the Libyan national essential medicines list and the WHO model list of essential medicines. Libyan J Med (2010) 0.75

The problem of self-administration of drugs; with particular reference to pulmonary tuberculosis. Tubercle (1958) 4.28

The use of legal action in New York City to ensure treatment of tuberculosis. N Engl J Med (1999) 2.96

Directly observed therapy for tuberculosis: history of an idea. Lancet (1995) 2.76

Control of tuberculosis by community health workers in Bangladesh. Lancet (1997) 2.55

Not to be taken as directed. BMJ (2003) 2.00

Tuberculosis control and directly observed therapy from the public health/human rights perspective. Int J Tuberc Lung Dis (1999) 1.60

Public health, civil liberties, and tuberculosis. BMJ (1999) 1.26

Patients with tuberculosis can be managed effectively in the community. BMJ (1999) 0.84

Problems in organising effective ambulatory treatment of tuberculosis patients. Bull Int Union Tuberc (1972) 0.83

The growing burden of tuberculosis: global trends and interactions with the HIV epidemic. Arch Intern Med (2003) 24.99

Epidemiology of antituberculosis drug resistance 2002-07: an updated analysis of the Global Project on Anti-Tuberculosis Drug Resistance Surveillance. Lancet (2009) 7.22

Drivers of tuberculosis epidemics: the role of risk factors and social determinants. Soc Sci Med (2009) 5.93

Tuberculosis. N Engl J Med (2013) 4.75

Evaluation of respondent-driven sampling. Epidemiology (2012) 4.75

Epidemiology of antituberculosis drug resistance (the Global Project on Anti-tuberculosis Drug Resistance Surveillance): an updated analysis. Lancet (2006) 4.73

International standards for tuberculosis care. Lancet Infect Dis (2006) 4.67

Latent Mycobacterium tuberculosis infection. N Engl J Med (2015) 4.62

Surveillance of anti-tuberculosis drug resistance in the world: an updated analysis, 2007-2010. Bull World Health Organ (2011) 4.19

The HIV-associated tuberculosis epidemic--when will we act? Lancet (2010) 3.82

Feasibility and cost-effectiveness of standardised second-line drug treatment for chronic tuberculosis patients: a national cohort study in Peru. Lancet (2002) 3.67

Improving tuberculosis control through public-private collaboration in India: literature review. BMJ (2006) 3.19

Is operational research delivering the goods? The journey to success in low-income countries. Lancet Infect Dis (2012) 2.62

Global epidemiology of tuberculosis: prospects for control. Semin Respir Crit Care Med (2008) 2.57

Prospects for tuberculosis elimination. Annu Rev Public Health (2012) 2.50

MDR tuberculosis--critical steps for prevention and control. N Engl J Med (2010) 2.49

Rapid molecular TB diagnosis: evidence, policy making and global implementation of Xpert MTB/RIF. Eur Respir J (2012) 2.47

Tuberculosis control in the era of HIV. Nat Rev Immunol (2005) 2.40

The global fight against HIV/AIDS, tuberculosis, and malaria: current status and future perspectives. Am J Clin Pathol (2009) 2.34

Cost and cost-effectiveness of PPM-DOTS for tuberculosis control: evidence from India. Bull World Health Organ (2006) 2.31

Drug-resistant tuberculosis: time for visionary political leadership. Lancet Infect Dis (2013) 2.16

Turning liabilities into resources: informal village doctors and tuberculosis control in Bangladesh. Bull World Health Organ (2006) 2.14

Global tuberculosis control: lessons learnt and future prospects. Nat Rev Microbiol (2012) 2.05

Social franchising of TB care through private GPs in Myanmar: an assessment of treatment results, access, equity and financial protection. Health Policy Plan (2007) 2.03

The WHO policy package to combat antimicrobial resistance. Bull World Health Organ (2011) 1.93

Promoting protection and pleasure: amplifying the effectiveness of barriers against sexually transmitted infections and pregnancy. Lancet (2006) 1.89

A global framework for action to improve the primary care response to chronic non-communicable diseases: a solution to a neglected problem. BMC Public Health (2009) 1.87

XDR-TB: entering the post-antibiotic era? Int J Tuberc Lung Dis (2006) 1.86

Implementation of isoniazid preventive therapy for people living with HIV worldwide: barriers and solutions. AIDS (2010) 1.77

Engaging hospitals to meet tuberculosis control targets in China: using the Internet as a tool to put policy into practice. Bull World Health Organ (2010) 1.76

Drug-resistant tuberculosis--current dilemmas, unanswered questions, challenges, and priority needs. J Infect Dis (2012) 1.72

Global epidemiology of tuberculosis. Semin Respir Crit Care Med (2013) 1.66

Extraspousal partnerships in a community in rural Uganda with high HIV prevalence: a cross-sectional population-based study using linked spousal data. J Acquir Immune Defic Syndr (2011) 1.65

Lives saved by tuberculosis control and prospects for achieving the 2015 global target for reducing tuberculosis mortality. Bull World Health Organ (2011) 1.64

Global epidemiology of tuberculosis. Clin Chest Med (2005) 1.59

The general population cohort in rural south-western Uganda: a platform for communicable and non-communicable disease studies. Int J Epidemiol (2013) 1.48

New drugs for the treatment of tuberculosis: needs, challenges, promise, and prospects for the future. J Infect Dis (2012) 1.46

Public-private mix for DOTS implementation: what makes it work? Bull World Health Organ (2004) 1.46

Resources required for global tuberculosis control. Science (2002) 1.43

How human immunodeficiency virus voluntary testing can contribute to tuberculosis control. Bull World Health Organ (2003) 1.43

Tuberculosis elimination: theory and practice in Europe. Eur Respir J (2014) 1.42

Modernizing surveillance of antituberculosis drug resistance: from special surveys to routine testing. Clin Infect Dis (2011) 1.41

Hard gains through soft contracts: productive engagement of private providers in tuberculosis control. Bull World Health Organ (2006) 1.39

Global burden and epidemiology of tuberculosis. Clin Chest Med (2009) 1.35

Operational evaluation of a service for prevention of mother-to-child transmission of HIV in rural Uganda: barriers to uptake of single-dose nevirapine and the role of birth reporting. Trop Med Int Health (2010) 1.25

Tuberculosis control is crucial to achieve the MDGs. Lancet (2010) 1.22

Stopping tuberculosis: time to turn urgent attention to hospitals. Int J Tuberc Lung Dis (2008) 1.22

Access to, and uptake of, antiretroviral therapy in a developing country with high HIV prevalence: a population-based cohort study in rural Uganda, 2004-2008. Trop Med Int Health (2012) 1.16

The impact of antiretroviral treatment on mortality trends of HIV-positive adults in rural Uganda: a longitudinal population-based study, 1999-2009. Trop Med Int Health (2012) 1.15

Global policy review of antiretroviral therapy eligibility criteria for treatment and prevention of HIV and tuberculosis in adults, pregnant women, and serodiscordant couples. J Acquir Immune Defic Syndr (2013) 1.12

Tuberculosis: still a social disease. Int J Tuberc Lung Dis (2011) 1.11

Global Fund financing of public-private mix approaches for delivery of tuberculosis care. Trop Med Int Health (2011) 1.11

Nutritional status of children living in a community with high HIV prevalence in rural Uganda: a cross-sectional population-based survey. Trop Med Int Health (2010) 1.10

Prevention, diagnosis, and treatment of tuberculosis in children and mothers: evidence for action for maternal, neonatal, and child health services. J Infect Dis (2012) 1.09

Developing the agenda for European Union collaboration on non-communicable diseases research in Sub-Saharan Africa. Health Res Policy Syst (2010) 1.08

Stopping tuberculosis in the 21st century: goals and strategies. Respirology (2010) 1.08

Antiretroviral therapy and sexual behavior in Uganda: a cohort study. AIDS (2011) 1.06

Scale up: meeting targets in global tuberculosis control. Lancet (2004) 1.04

The health workforce crisis in TB control: a report from high-burden countries. Hum Resour Health (2005) 1.04

Action on noncommunicable diseases: balancing priorities for prevention and care. Bull World Health Organ (2011) 1.03

Active case-finding for TB in the community: time to act. Lancet (2010) 1.03

Implementing the global plan to stop TB, 2011-2015--optimizing allocations and the Global Fund's contribution: a scenario projections study. PLoS One (2012) 1.01

Tuberculosis and HIV in people who inject drugs: evidence for action for tuberculosis, HIV, prison and harm reduction services. Curr Opin HIV AIDS (2012) 1.00

Managing tuberculosis in people who use and inject illicit drugs. Bull World Health Organ (2013) 1.00

Using verbal autopsy to assess the prevalence of HIV infection among deaths in the ART period in rural Uganda: a prospective cohort study, 2006-2008. Popul Health Metr (2011) 1.00

Mortality of HIV-infected and uninfected children in a longitudinal cohort in rural south-west Uganda during 8 years of follow-up. Trop Med Int Health (2012) 0.99

The research agenda for improving health policy, systems performance, and service delivery for tuberculosis control: a WHO perspective. Bull World Health Organ (2002) 0.98

Translating HIV/AIDS research findings into policy: lessons from a case study of 'the Mwanza trial'. Health Policy Plan (2002) 0.97

What research is needed to stop TB? Introducing the TB Research Movement. PLoS Med (2011) 0.97

Effect of pregnancy on immunological and virological outcomes of women on ART: a prospective cohort study in rural Uganda, 2004-2009. Trop Med Int Health (2011) 0.95

Tuberculosis fueled by HIV: putting out the flames. Am J Respir Crit Care Med (2007) 0.92

Global Tuberculosis Control: Toward the 2015 Targets and Beyond. Ann Intern Med (2015) 0.92

Tuberculosis and air travel: WHO guidance in the era of drug-resistant TB. Travel Med Infect Dis (2007) 0.92

Limitations on human rights: are they justifiable to reduce the burden of TB in the era of MDR- and XDR-TB? Health Hum Rights (2008) 0.91

Quality care: a link between clinical and public health approaches to HIV infection in developing countries. Trop Med Int Health (2010) 0.90

Transforming the global tuberculosis response through effective engagement of civil society organizations: the role of the World Health Organization. Bull World Health Organ (2011) 0.90

Perspective: Weigh all TB risks. Nature (2013) 0.88

MDR and XDR - the price of delaying engagement with all care providers for control of TB and TB/HIV. Trop Med Int Health (2007) 0.88

Updating the International Standards for Tuberculosis Care. Entering the era of molecular diagnostics. Ann Am Thorac Soc (2014) 0.87

Monitoring global health: WHO has mandate and expertise. BMJ (2005) 0.86

Trauma airway management: transition from anesthesia to emergency medicine. J Emerg Med (2013) 0.85

Prevalence of severe mental distress and its correlates in a population-based study in rural south-west Uganda. BMC Psychiatry (2011) 0.85

WHO policies for tuberculosis control. Lancet (2004) 0.84

Toward tuberculosis elimination in low-incidence countries: reflections from a global consultation. Ann Intern Med (2014) 0.83

The power of data: using routinely collected data to improve public health programmes and patient outcomes in low- and middle-income countries. Trop Med Int Health (2013) 0.83

Contribution of population factors to estimation of human immunodeficiency virus prevalence trends: a cohort study in rural Uganda, 1989-2007. Am J Epidemiol (2011) 0.82

Reply to 'Addressing smoking cessation in tuberculosis control'. Bull World Health Organ (2007) 0.82

Latent Mycobacterium tuberculosis Infection. N Engl J Med (2015) 0.80

Erring on the side of action: time for HIV programmes to implement isoniazid preventive therapy. Int J Tuberc Lung Dis (2009) 0.80

Scaling up public-private mix: collaborate or regulate? Int J Tuberc Lung Dis (2013) 0.79